Libman-Sachs Endocarditis

Libman-Sachs endocarditis (LSE) is a bacterial heart disease caused by streptococcal infection. It manifests itself in the form of inflammation of the inner lining of the heart - the endocardium.

Liebman-Sachs was an American physician who first described this disease in 1911. He observed patients with symptoms of LSE that were caused by streptococcal infections.

In the 1920s, it was discovered that LSE could be caused by various types of streptococcal infections, such as tonsillitis, pharyngitis, and sinusitis. In the 1930s, it became clear that streptococcal infection could spread to the heart through the blood.

Symptoms of FSE may include fever, chest pain, shortness of breath, cough and other signs of infection. In severe cases, LSE can lead to heart failure and even death.

Treatment for FSE includes antibiotic therapy and surgical removal of infected areas of the heart. In some cases, if the infection has spread to the heart valves, the valve may need to be replaced.

Today, FSE remains one of the most common bacterial heart diseases. However, thanks to the development of antibiotics and improved treatment methods, the survival rate of patients with FSE has increased significantly.

Libman-Sakus Endocarditis (E. Libman, 1823-11064 L. M. Sacks) is a specific inflammatory disease of the inner lining of the heart, which affects the autoimmune leaf of the aureona lining the cavities of the heart, valves, capillaries and sinus blood vessels. This is a rare disease that usually presents with an acute fever. Over time, inflammation of other organs may occur, including the lungs, gastrointestinal tract, and skin.